Skip to main content

Cardiff Oncology, Inc 8-K, filed Oct 22, 2026

Cardiff Oncology, Inc. (CRDF)

8-K 2026-10-22 For: 2026-10-22
View Original
Added on October 23, 2026

About this 8-K

Cardiff Oncology, Inc filed this 8-K on October 22, 2026.

Cardiff Oncology stockholders approved increasing authorized capital stock from 170,000,000 to 320,000,000 and authorized common stock from 150,000,000 to 300,000,000 at the October 22, 2026 Special Meeting. AI summary

Items reported

  • Item 5.07: Shareholder vote results